Precigen (PGEN) Gross Margin Growth (1y) (2014 - 2026)
Powered by 
Analysis
Precigen (PGEN) Gross Margin Growth (1y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | -93.00 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | -91.00 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 210.00 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 1,966.00 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 228.00 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | -475.00 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 1,034.00 |
| 10 | Precigen | 2.53 Bn | 2.53 Bn | 52.17 Mn | 12,247.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 12,247.00 |
| Mar 31, 2026 | 7,102.00 |
| Dec 31, 2025 | 6,327.00 |
| Sep 30, 2025 | 7,046.00 |
| Jun 30, 2025 | 1,385.00 |
| Mar 31, 2025 | 1,891.00 |
| Dec 31, 2024 | 1,235.00 |
| Sep 30, 2024 | 558.00 |
| Jun 30, 2024 | -4,538.00 |
| Mar 31, 2024 | -1,844.00 |
| Dec 31, 2023 | -3,929.00 |
| Sep 30, 2023 | -10,203.00 |
| Jun 30, 2023 | -3,383.00 |
| Mar 31, 2023 | -5,177.00 |
| Dec 31, 2022 | 707.00 |
| Sep 30, 2022 | 1,967.00 |
| Jun 30, 2022 | -3,825.00 |
| Mar 31, 2022 | -53.00 |
| Dec 31, 2021 | -16,191.00 |
| Sep 30, 2021 | 183.00 |